fundmomentum.vc

Epidarex Capital Fund IV

United Kingdom
Seed
Share

About Epidarex Capital Fund IV

Transatlantic life-science fund secured $145M first close for Fund IV to fuel early-stage drug discovery and healthtech startups in the UK and US.

Investment Focus

Location / RegionUnited Kingdom
Funding StageSeed
Industry Focus
Biotech
Med Tech

Investor Signals Profile

unknown

Sweet Spot

No sweet spot defined.

immunology
rare disease
nephrology
biopharma
complement biology
oncolytic immunotherapy
oncology

Bullish Signals

Portfolio co Apellis acquired by Biogenexternal
Biogen-Apellis deal boosts nephrology thesiswebsite
Exit validates immunology/rare disease focuswebsite
Theolytics Phase 1 trial first patient dosedwebsite
Ovarian cancer trial recruitment on trackwebsite
THEO-260 IP dosing in platinum-resistant ovarian cancerwebsite

Contrarian Signals

No contrarian signals recorded.

Founder Do's

No pitch recommendations recorded.

Founder Don'ts

No red flags recorded.

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View PlansBrowse all Signal Profiles →

Fund Overview

Fund Size€122M
Saves0
Website
LinkedIn

Key People

Sinclair Dunlop

Related Funds

Re7 Capital SocialFi Fund

$10M
United Kingdom
Pre Seed
Ai Ml, Web3 Infrastructure, Ecommerce, Consumer Commerce, Saas
Fund Manager:Luc De Leyritz, Evgeny Gokhberg
Pre Seed
Ai Ml
Web3 Infrastructure
Ecommerce
Consumer Commerce
Saas

Vesper Next Generation Infrastructure Fund I

€570M
United Kingdom
Pre Seed
Ai Ml, Climate Sustainability, Saas
Fund Manager:Livio Fenati, Aola Rastelli, Giacomo Rossi
Pre Seed
Ai Ml
Climate Sustainability
Saas

Adams Street European Venture Fund I

€270M
United Kingdom
Pre Seed
Enterprise Software
Fund Manager:Ross Morrison
Pre Seed
Enterprise Software